Literature DB >> 1546132

Mode of action and characteristics of monoamine oxidase-A inhibition by moclobemide.

A M Cesura1, R Kettler, R Imhof, M Da Prada.   

Abstract

The mode of interaction of the reversible monoamine oxidase-A (MAO-A) inhibitor moclobemide with the enzyme was investigated. The inhibition of rat brain or human placenta MAO-A by moclobemide showed an initial competitive phase, with a relatively low affinity (KI = 0.2-0.4 mM). However, the potency of the inhibitor was increased with incubation time. The time-dependent component of the association of moclobemide with MAO-A followed pseudo-first order kinetics. In contrast to mechanism-based inhibitors, no indication for adduct or product formation was detected after incubation of moclobemide with the enzyme. Even though some aspects of the moclobemide interaction with MAO-A are still not completely elucidated, this compound seems to have the characteristics of a slow-binding inhibitor.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1546132     DOI: 10.1007/bf02246226

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  7 in total

Review 1.  Enzyme-activated/mechanism-based inhibitors.

Authors:  M G Palfreyman; P Bey; A Sjoerdsma
Journal:  Essays Biochem       Date:  1987       Impact factor: 8.000

2.  Pharmacological profile of moclobemide, a short-acting and reversible inhibitor of monoamine oxidase type A.

Authors:  W P Burkard; E P Bonetti; M Da Prada; J R Martin; P Polc; R Schaffner; R Scherschlicht; F Hefti; R K Müller; P C Wyss
Journal:  J Pharmacol Exp Ther       Date:  1989-01       Impact factor: 4.030

3.  Characterization of the binding of [3H]Ro 41-1049 to the active site of human monoamine oxidase-A.

Authors:  A M Cesura; M Bös; M D Galva; R Imhof; M Da Prada
Journal:  Mol Pharmacol       Date:  1990-03       Impact factor: 4.436

4.  Neurochemical profile of moclobemide, a short-acting and reversible inhibitor of monoamine oxidase type A.

Authors:  M Da Prada; R Kettler; H H Keller; W P Burkard; D Muggli-Maniglio; W E Haefely
Journal:  J Pharmacol Exp Ther       Date:  1989-01       Impact factor: 4.030

5.  Analysis of radioligand binding experiments. A collection of computer programs for the IBM PC.

Authors:  G A McPherson
Journal:  J Pharmacol Methods       Date:  1985-11

6.  The kinetics of reversible tight-binding inhibition.

Authors:  J W Williams; J F Morrison
Journal:  Methods Enzymol       Date:  1979       Impact factor: 1.600

7.  [3H]Ro 19-6327: a reversible ligand and affinity labelling probe for monoamine oxidase-B.

Authors:  A M Cesura; M D Galva; R Imhof; E Kyburz; G B Picotti; M Da Prada
Journal:  Eur J Pharmacol       Date:  1989-03-29       Impact factor: 4.432

  7 in total
  4 in total

1.  Effect of oral linezolid on the pressor response to intravenous tyramine.

Authors:  Mireille V Cantarini; Catherine J Painter; Elaine M Gilmore; Catherine Bolger; Claire L Watkins; Andrew M Hughes
Journal:  Br J Clin Pharmacol       Date:  2004-11       Impact factor: 4.335

Review 2.  Biochemistry and pharmacology of moclobemide, a prototype RIMA.

Authors:  W Haefely; W P Burkard; A M Cesura; R Kettler; H P Lorez; J R Martin; J G Richards; R Scherschlicht; M Da Prada
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

3.  Monoamine oxidase-A: pharmacodynamics in humans of moclobemide, a reversible and selective inhibitor.

Authors:  N H Holford; T W Guentert; J Dingemanse; L Banken
Journal:  Br J Clin Pharmacol       Date:  1994-05       Impact factor: 4.335

Review 4.  A risk-benefit assessment of moclobemide in the treatment of depressive disorders.

Authors:  T R Norman; G D Burrows
Journal:  Drug Saf       Date:  1995-01       Impact factor: 5.606

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.